Please sign in to follow a disease.
Can a website help melanoma survivors stay Sun-Safe? new study says maybe.
NCT ID NCT03028948
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested whether an interactive website could help 485 melanoma survivors do better at protecting their skin from the sun and checking their skin for new or returning cancers. Participants used the website and reported how often they used sunscreen, wore protective clothing, and performed thorough skin self-exams. The goal was to see if a simple online tool could improve these healthy behaviors.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Interactive tailored website
- What this could lead to
- If successful, this could point toward an effective, low-cost digital tool to help melanoma survivors protect their skin and catch new cancers early.
- What could go wrong
- This is a completed behavioral study, not a treatment trial. The website may not work for everyone, and results may not apply to people without internet access or who don't speak English.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
485 people
The number who actually took part.
- Started
-
Jan 2017
- Finished
-
Aug 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Phase I: Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma * Phase I: From 3-36 months post-surgical treatment * Phase I: Access to the internet * Phase I: Able to speak and read English * Phase I: Able to provide informed consent * Phase II: Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma * Phase II: From 3-24 months post-surgical treatment * Phase II: Not adherent to thorough SSE (i.e., did not check every area of the body at least once during the past 2 months) * Phase II: Not adherent to sun protection recommendations (i.e., mean score \< 4 \[which corresponds to "often"\] on a 5-point scale \[from 1 = "never" to 5 = "always"\] that assesses the frequency of engaging in four sun protection behaviors) * Phase II: Access to a computer connected to the internet * Phase II: Able to speak and read English * Phase II: Able to provide informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Stage 0 skin melanoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903, United States
-
University of Virginia
Charlottesville, Virginia, 22904, United States